Articles > Health magazines > Nursing and Health magazines > Health & Beauty Close-Up articles > August 2008

Article: Metabasis Therapeutics to Present Results from Its Phase 2a Clinical Trial for MB07803.

Article from:
Health & Beauty Close-Up
Article date:
August 1, 2008
Copyright

HEALTH AND BEAUTY CLOSE-UP-1 August 2008-Metabasis Therapeutics to Present Results from Its Phase 2a Clinical Trial for MB07803(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com

Metabasis Therapeutics announced that an oral presentation summarizing the results from the Company's Phase 2a clinical trial for MB07803 will be given at the World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy), to be held in Barcelona, Spain, October 30 to November 2.

In a release the Company noted the following:

MB07803 is the Company's second-generation fructose-1,6-bisphosphatase (FBPase) inhibitor for the treatment of type 2 ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Metabasis Therapeutics Announces Initiation of a ...
Clinical Trials Week;  October 6, 2008 ;     700+ words ...Metabasis Therapeutics, Inc ... initiated a clinical trial to evaluate ... see also Metabasis Therapeutics, Inc ... MB07803. This clinical trial provided ... Keywords: Clinical Trial Research ... Mellitus, Metabasis Therapeutics Inc. This ...

Article: Metabasis Therapeutics Announces Positive Results ...
Diabetes Week;  April 6, 2009 ;     700+ words ...Metabasis Therapeutics, Inc ... announced results from a clinical trial in which MB07803 was ... 2 diabetes (see also Metabasis Therapeutics, Inc.). The clinical trial was designed to investigate ...

Article: Metabasis Therapeutics Announces Initiation of a ...
Business Wire;  June 20, 2007 ;     700+ words ...SAN DIEGO -- Metabasis Therapeutics, Inc. (Nasdaq ... initiated a Phase 1b clinical trial for MB07811, a ... completed a Phase 1a clinical trial for MB07811 at the ... dose. The current clinical trial, designated as ...

Article: Metabasis Therapeutics Reports Results in a ...
Health & Beauty Close-Up;  March 28, 2009 ;     700+ words ...Metabasis Therapeutics, Inc. announced results from a clinical trial in which MB07803 was administered ... type 2 diabetes. The clinical trial was designed to investigate ... ascending multiple dose clinical trial. Patients received either ...

Article: Metabasis Therapeutics Initiates a Phase 1 ...
PR Newswire;  October 30, 2006 ;     700+ words ... ... DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Metabasis Therapeutics, Inc. , a biopharmaceutical company focused ... announced today that it has initiated a Phase 1 clinical trial of MB07811, a novel, orally active product ...

Article: Metabasis Therapeutics, Inc. Announces That Results ...
PR Newswire;  October 5, 2004 ;     700+ words ...Metabasis Therapeutics, Inc. announced ... recently completed clinical trial of remofovir in patients ... based on data from a clinical trial of remofovir, which ... Data from this clinical trial will be presented ...

Article: Metabasis Therapeutics Announces Positive Results ...
Business Wire;  April 28, 2008 ;     700+ words ...SAN DIEGO -- Metabasis Therapeutics, Inc. (Nasdaq ... in its Phase 2a clinical trial. The study also ... proof-of-concept clinical trial was a randomized ... 0177). This clinical trial showed that MB07803 ...

Article: Metabasis Therapeutics Completes Enrollment of Its ...
Business Wire;  February 28, 2008 ;     700+ words ...SAN DIEGO -- Metabasis Therapeutics, Inc. (Nasdaq ... in its Phase 2a clinical trial for MB07803, a ... once daily. The clinical trial is evaluating the ... endpoint in a Phase 2b clinical trial in 2007. Subsequent ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives